This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Anaemia and flying (fitness to fly)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • Sickle cell trait does not present a particular problem at normal cruising altitude. However, patients with sickle cell anaemia should travel with supplemental oxygen and should defer travel for approximately 10 days following a sickling crisis (1)
  • patients with a haemoglobin of greater than 8 g/dl may travel without problems assuming there is no coexisting condition such as cardiovascular or respiratory disease (1)

  • if the haemoglobin is less than 7.5 g/dl, special assessment should be made and the use of supplemental oxygen should be considered (1)

Note guidance varies between sources (2,3):

  • anaemia - may require in flight oxygen. A haemoglobin below 8.5 g/dl requires special consideration before permitting to fly (2,3).
    • a haemoglobin below 7.5 g/dl is generally a contraindication to air travel (3)

  • individuals with chronic renal insufficiency or other medical condition predisposing to anaemia, which is chronic in nature, will usually tolerate a lower haemoglobin level than if the anaemia is of acute onset.

Note that these are only guidelines - each airline has its own regulations and medical standards and these must be consulted before travel

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.